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ChIP-ChipQuiescent stem cells contribute to tissue homeostasis and repair in adult mammals. We identiﬁed a tumor
suppressor PRDM2, as an epigenetic regulator induced in quiescent muscle stem cells as well as in cultured
quiescent myoblasts. To delineate the functions of PRDM2 in muscle cells, we compared the gene expression
proﬁles of control and PRDM2 knockdown myoblasts in growing, differentiating and quiescent conditions
(GEO accession number: GSE 58676). To identify the direct targets of PRDM2 and the promoters co-associated
with H3K9me2 (mark catalyzed by PRDM2), ChIP-Chip analysis was performed (GSE58748). In this report we
discuss in detail themethodology used to identify PRDM2 regulated genes and classify them into potential direct
and indirect targets.
© 2015 Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).oblasts
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cgi?acc=GSE58748.2. Experimental design, materials and methods2.1. Cell cultureC2C12 myoblasts originally obtained from H. Blau, Stanford were
sub-cloned and screened to obtain clones that exhibited tight growth
control and robust differentiation. Cells were maintained in growth
mediumcontaining DMEM [high glucose] + 20% fetal bovine serum +
antibiotics. Differentiation was induced at 80–90% conﬂuence by
switching cultures to low mitogen medium containing DMEM + 2%
horse serum. Growing C2C12 myoblasts were induced to arrest in G0
phase of cell cycle by suspension culture in 1.3%methyl-cellulosemedi-
um containing 20% fetal bovine serum+ antibiotics.2.2. Generation of stable myoblast pools expressing GFPsh or PRDM2shSmall hairpin (sh) RNAs targeting PRDM2 and control GFP
transcripts were obtained using Oligoretriever (URL: http://www.
cshl.org/public/SCIENCE/hannon.html), sequences are given in [1]
and cloned into mU6 vector. Growing C2C12 myoblasts were co-
transfected with mU6 vector containing shRNA along with pSV2
neo plasmid at 5:1 ratio. To obtain stable pools, cells were selected
in medium containing G418 (500 μg/ml) for 7 days with daily
medium change. Stable pools were frozen after selection andhttp://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Scatter plot generated using SAM tools shows genes whose expression is
signiﬁcantly changed between proliferating PRDM2sh and GFPsh myoblasts; duplicate
arrays were used for the analysis. Up-regulated genes are indicated in red, black indicates
unchanged genes and green indicates down-regulated genes.
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used for one passage only.
2.3. RNA extraction
G0 arrested myoblasts from suspension culture were collected by
diluting in PBS followed by centrifugation. Cells were washed with
PBS and collected into TRIzol (Invitrogen) on ice. Growing and 28 h dif-
ferentiatedmyoblasts were washed brieﬂy with PBS on the culture dish
and TRIzol added onto the cells directly followed by scraping to collect
lysates. Total RNA from samples in TRIzol was isolated according to
the manufacturer's instructions.
2.4. Conﬁrmation of the extent of knockdown
RNA samples were analyzed by real time q-RT-PCR on an ABI7700
cycler to conﬁrm the suppression of PRDM2 expression in PRDM2sh
myoblasts. Knockdown of Riz1 and Riz2 transcripts were observed [1].Fig. 2. Example of probe intensity and distribution of signal (A) Histogram showing distributio
normalized intensities of IP vs Input showing probe enrichment.2.5. Microarray proﬁling of growing GFPsh and PRDM2sh myoblast using
NIA15k mouse array
PRDM2 knock down leads to precocious expression of muscle dif-
ferentiation markers even in growth inducing conditions [1]. To under-
stand the global gene deregulation, microarray analysis was performed
by competitive hybridization of Cy3 and Cy5 labeled cDNA prepared
using Superscript II® (Invitrogen) with 20 μg of total RNA obtained
from GFPsh and PRDM2sh myoblasts. Equimolar (25–30 picomolar)
quantities of puriﬁed labeled cDNA was hybridized competitively to
NIA15Kmouse spotted cDNA arrays at 42 °C for 16 h (University Health
Network/Ontario Cancer Institute) according to protocols provided
by Amersham/GE. The arrays were washed with 1× SSC and 0.2%
SDS followed by 0.1× SSC and 0.2% SDS and 0.1× SSC. Slides were
dried and scanned using a Molecular Dynamics scanner. Array Vision
software was used for feature extraction, background subtraction,
assigning detection limit and for spot intensity calculations. Lowess
normalization was done using TIGR's Microarray Data Analysis Sys-
tem (TIGR MIDAS) [2]. Two independent hybridizations including a
dye reversal for each sample and two biological replicates were per-
formed. SAM (Signiﬁcance Analysis of Microarrays) tools were used
to obtain differentially expressed genes with FDR ≤ 0.05 and 1.5
fold cutoff. A graphic representation of scatter plot obtained with
SAM tools was shown in Fig. 1. Raw data is deposited in GEOwith ac-
cession number GSE58675.2.6. Microarray proﬁling of G0 arrested and 28 h differentiated myoblasts
Proliferating PRDM2sh myoblasts showed subtle changes in gene
expression compared to GFPsh myoblasts suggesting that the major
function of this chromatin remodeler could be at other cell cycle
stages. To better understand the functions of PRDM2, we performed
microarray analysis with PRDM2sh myoblasts under quiescent and
differentiating conditions with triplicate samples including biologi-
cal replicates. 8 μg of total RNA was converted into cDNA using
Affymetrix (Santa Clara, CA) one cycle labeling kit. cDNAwas column
puriﬁed and further subjected to RNA ampliﬁcation using an
Affymetrix IVT labeling kit. Equal amount of biotin labeled cRNA
was fragmented (into 50–200 bp fragments) and hybridized to
Affymetrix Genome 430 2.0 arrays, further slides were washed,
stained and scanned as per Affymetrix protocols.n of normalized Log2 ratios for all probes in PRDM2 ChIP-Chip data set. B. Scatter plot of
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The data was analyzed by using the Gene Chip operating software
(GCOS) of Affymetrix to generate CEL (cell intensity) ﬁles. Further CEL
ﬁles were uploaded to AvadisTM software version 4.3 (an Affymetrix
approved software manufactured by Strand Life Sciences, Bangalore,
India) for further analysis. The CEL ﬁles of GFPsh samples were treated
as control group and PRDM2sh samples were treated as experimental
group in G0 and D28. The data normalization was performed using
PLIER algorithm and genes with differential expression of ≥1.5 fold, ei-
ther upregulated or downregulated with p ≤ 0.05 were processed for
further analysis. Raw data ﬁles were deposited in GEO with accession
numbers for quiescent PRDM2sh and GFPsh myoblasts GSE58674 and
D28 PRDM2sh and control GFPsh myoblasts with GSE58673.
2.8. ChIP-Chip analysis of quiescent myoblasts
C2C12 myoblasts were recovered from non-adherent G0 conditions
by dilution of methocel in PBS followed by centrifugation. Crosslinking
was performed by re-suspending cells in growth medium containing
1% formaldehyde (Sigma) at 37 °C for 10 min. Crosslinking was ter-
minated by adding 0.125 M glycine followed by washes with ice-cold
PBS. Around 1 × 106 cells were lysed in 200 μl of SDS lysis buffer, follow-
ed by sonication with 45 s on/off for 25 cycles at high power
(BioRuptor® sonicator) to obtain chromatin fragments of size ranging
from 200 to 600 bp. Fragmented chromatin was diluted 10 times with
ChIP dilution buffer and pre-cleared with Protein A/G beads containing
salmon sperm DNA. Cleared supernatants were incubated with 5 μg of
PRDM2 polyclonal antibody (that detects both isoforms RIZ1 and RIZ2
#Ab3790) and 2.5 μg H3K9me2 (Ab1220) for 16 h at 4 °C on a rotary
shaker. Immune complexes were collected by adding Protein A/G aga-
rose beads + salmon sperm DNA mix (Millipore). The beads were
washed sequentially with low salt, high salt, LiCl, and TE wash buffers
(buffer compositionswere fromMillipore Chromatin Immunoprecipita-
tion assay kit 17–295) at 4 °C on a rotary shaker followed by centrifuga-
tion at 3200 ×g for 5 min. Immune complexes were eluted at RT for
15 min twice followed by reverse crosslinking at 65 °C with 5 M NaCl
for 16 h and proteinase K digestion. DNA puriﬁcation was carried out
using Qiagen nucleotide removal kit.
2.9. Hybridization
Puriﬁed DNA sample of IP and Input were blunt ended using T4
DNA polymerase followed by ligation and ampliﬁcation. The linker
sequences used were JW102GCGGTGACCCGGGAGATCTGAATTC and
JW103GAATTCAGATC. Ampliﬁed IP and input DNA was recovered by
ethanol precipitation followed by labeling with Cy3 and Cy5 dyes
using Agilent genomic DNA labeling kit plus (Agilent p/n 5188–5309).
Labeled sampleswere puriﬁed usingMicrocon YM-30 ﬁlter and quanti-
ﬁed by Nano-Drop ND-1000 UV–Vis spectrophotometer. 2.5 μg to 5 μgof Cy3 and Cy5 labeled DNA was used for hybridization at 65 °C for
40 h, 20 RPM on to a 1X244k promoter array fromAgilent technologies.
Post hybridization slides were washed with wash buffers (Agilent)
according to manufacturer instructions.
2.10. Data Analysis
Slides were scanned on an Agilent scanner and images were ana-
lyzed using Agilent feature extraction software. Text ﬁles generated by
Agilent feature extraction software were normalized by median blank
subtraction, inter-array median normalization and dye bias normaliza-
tion by DNA Analytics software. Whitehead per-array neighborhood al-
gorithm was used to detect robust peaks corresponding to the DNA
binding. Enrichment values for all probes were obtained by normalized
log IP/Input and probes with p value ≤ 0.05 were considered for further
analysis (Fig. 2). ChIP-Chip with PRDM2 antibody was performed with
two biological replicates and one array was used for H3K9me2. The
data were deposited in GEO with the accession number GSE58748.
3. Conclusions
Here we describe complete methodology used to perform micro-
array and ChIP-Chip to identify the genes regulated by PRDM2. We
used this data set recently in a study describing the role of PRDM2 in
regulating quiescence by repressing myogenesis and preserving the
cell cycle genes from permanent silencing [1].
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